FdaApplication
BLA 125349
Identifiers
- fda_app_no: BLA125349
Properties
| Property | Value |
|---|---|
| applicant_name | Emergent BioDefense Operations Lansing LLC |
| application_type | BLA |
| approval_date | 2012-12-14 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RAXIBACUMAB | RAXIBACUMAB | 1,700MG/34ML (50MG/ML) | INJECTABLE;IV (INFUSION) |
1 product